vs
Side-by-side financial comparison of Piedmont Realty Trust, Inc. (PDM) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $143.3M, roughly 1.1× Piedmont Realty Trust, Inc.). Piedmont Realty Trust, Inc. runs the higher net margin — -31.4% vs -82.0%, a 50.6% gap on every dollar of revenue. On growth, Piedmont Realty Trust, Inc. posted the faster year-over-year revenue change (0.4% vs -22.7%). Over the past eight quarters, Piedmont Realty Trust, Inc.'s revenue compounded faster (0.0% CAGR vs -11.5%).
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
PDM vs PTCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $143.3M | $164.7M |
| Net Profit | $-45.0M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | — | -43.3% |
| Net Margin | -31.4% | -82.0% |
| Revenue YoY | 0.4% | -22.7% |
| Net Profit YoY | -27.9% | -104.8% |
| EPS (diluted) | $-0.10 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $143.3M | — | ||
| Q4 25 | $142.9M | $164.7M | ||
| Q3 25 | $139.2M | $211.0M | ||
| Q2 25 | $140.3M | $178.9M | ||
| Q1 25 | $142.7M | $1.2B | ||
| Q4 24 | $143.2M | $213.2M | ||
| Q3 24 | $139.3M | $196.8M | ||
| Q2 24 | $143.3M | $186.7M |
| Q1 26 | $-45.0M | — | ||
| Q4 25 | $-43.2M | $-135.0M | ||
| Q3 25 | $-13.5M | $15.9M | ||
| Q2 25 | $-16.8M | $-64.8M | ||
| Q1 25 | $-10.1M | $866.6M | ||
| Q4 24 | $-30.0M | $-65.9M | ||
| Q3 24 | $-11.5M | $-106.7M | ||
| Q2 24 | $-9.8M | $-99.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | -43.3% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | -19.5% | ||
| Q1 25 | — | 82.5% | ||
| Q4 24 | — | -76.2% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | — | -21.5% |
| Q1 26 | -31.4% | — | ||
| Q4 25 | -30.3% | -82.0% | ||
| Q3 25 | -9.7% | 7.5% | ||
| Q2 25 | -12.0% | -36.3% | ||
| Q1 25 | -7.1% | 73.7% | ||
| Q4 24 | -20.9% | -30.9% | ||
| Q3 24 | -8.3% | -54.2% | ||
| Q2 24 | -6.8% | -53.1% |
| Q1 26 | $-0.10 | — | ||
| Q4 25 | $-0.34 | $-1.63 | ||
| Q3 25 | $-0.11 | $0.20 | ||
| Q2 25 | $-0.14 | $-0.83 | ||
| Q1 25 | $-0.08 | $10.04 | ||
| Q4 24 | $-0.25 | $-0.85 | ||
| Q3 24 | $-0.09 | $-1.39 | ||
| Q2 24 | $-0.08 | $-1.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.3M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.5B | $-205.3M |
| Total Assets | $4.0B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.3M | — | ||
| Q4 25 | $731.0K | $1.9B | ||
| Q3 25 | $3.0M | $1.7B | ||
| Q2 25 | $3.3M | $2.0B | ||
| Q1 25 | $2.9M | $2.0B | ||
| Q4 24 | $109.6M | $1.1B | ||
| Q3 24 | $133.6M | $1.0B | ||
| Q2 24 | $138.5M | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | — |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.5B | $-205.3M | ||
| Q3 25 | $1.5B | $-155.8M | ||
| Q2 25 | $1.5B | $-206.5M | ||
| Q1 25 | $1.6B | $-185.8M | ||
| Q4 24 | $1.6B | $-1.1B | ||
| Q3 24 | $1.6B | $-1.1B | ||
| Q2 24 | $1.7B | $-980.2M |
| Q1 26 | $4.0B | — | ||
| Q4 25 | $4.0B | $2.9B | ||
| Q3 25 | $4.0B | $2.6B | ||
| Q2 25 | $4.0B | $2.6B | ||
| Q1 25 | $4.0B | $2.7B | ||
| Q4 24 | $4.1B | $1.7B | ||
| Q3 24 | $4.1B | $1.8B | ||
| Q2 24 | $4.2B | $1.9B |
| Q1 26 | — | — | ||
| Q4 25 | 1.49× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 1.41× | — | ||
| Q1 25 | 1.40× | — | ||
| Q4 24 | 1.40× | — | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 1.34× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | 110.3% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $140.6M | $-34.3M | ||
| Q3 25 | $35.8M | $-66.3M | ||
| Q2 25 | $50.1M | $-58.3M | ||
| Q1 25 | $3.7M | $870.1M | ||
| Q4 24 | $198.1M | $-30.0M | ||
| Q3 24 | $42.9M | $-77.0M | ||
| Q2 24 | $66.8M | $-71.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% |
| Q1 26 | 110.3% | — | ||
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
